Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease.

Being major sources of reactive oxygen species (ROS), mitochondrial structures are exposed to high concentrations of ROS and might therefore be particularly susceptible to oxidative injury. Mitochondrial damage may play a pivotal role in the cell death decision. Bolstered evidence indicates that mitochondrial abnormalities might be part of the spectrum of chronic oxidative stress occurring in Alzheimer's disease (AD) finally contributing to synaptic failure and neuronal degeneration. Accumulation and oligomerization of amyloid beta (Abeta) is also thought to play a central role in the pathogenesis of this disease by probably directly leading to mitochondrial dysfunction. Moreover, numerous lines of findings indicate increased susceptibility to apoptotic cell death and increased oxidative damage as common features in neurons from sporadic AD patients but also from familial AD (FAD) cases. Here we provide a summary of recent work demonstrating some key abnormalities that may initiate and promote pathological events in AD. Finally, we emphasize a hypothetical sequence of the pathogenic steps linking sporadic AD, FAD, and Abeta production with mitochondrial dysfunction, caspase pathway, and neuronal loss.

[1]  G. Forloni,et al.  Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. , 1993, Neuroreport.

[2]  M. Mattson,et al.  Superoxide mediates the cell‐death‐enhancing action of presenilin‐1 mutations , 1999, Journal of neuroscience research.

[3]  S. Leutner,et al.  Effects of EGb 761® Ginkgo biloba Extract on Mitochondrial Function and Oxidative Stress , 2003, Pharmacopsychiatry.

[4]  S. Rapoport,et al.  Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. , 1994, Brain research. Molecular brain research.

[5]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J C Reed,et al.  Mitochondria and apoptosis. , 1998, Science.

[7]  M. Orth,et al.  Mitochondria and degenerative disorders. , 2001, American journal of medical genetics.

[8]  L. Pellegrini,et al.  Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-X(L). A potential role in modulating the threshold of cell death. , 1999, The Journal of biological chemistry.

[9]  M. Greenberg,et al.  β-Amyloid Induces Neuronal Apoptosis Via a Mechanism that Involves the c-Jun N-Terminal Kinase Pathway and the Induction of Fas Ligand , 2001, The Journal of Neuroscience.

[10]  D. Wallace Mitochondrial DNA mutations in diseases of energy metabolism , 1994, Journal of bioenergetics and biomembranes.

[11]  A. Leslie,et al.  The rotary mechanism of ATP synthase. , 2000, Current Opinion in Structural Biology.

[12]  N. Bresolin,et al.  Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. , 1999, Science.

[13]  M. Mattson,et al.  Alzheimer’s Presenilin Mutation Sensitizes Neural Cells to Apoptosis Induced by Trophic Factor Withdrawal and Amyloid β-Peptide: Involvement of Calcium and Oxyradicals , 1997, The Journal of Neuroscience.

[14]  Stanley I. Rapoport,et al.  Gene expression of ND4, a subunit of complex I of oxidative phosphorylation in mitochondria, is decreased in temporal cortex of brains of Alzheimer's disease patients , 1996, Brain Research.

[15]  C. Cotman,et al.  DNA Damage and Activated Caspase-3 Expression in Neurons and Astrocytes: Evidence for Apoptosis in Frontotemporal Dementia , 2000, Experimental Neurology.

[16]  M. Hennerici,et al.  Elevated Levels of Fragmented DNA Nucleosomes in Native and Activated Lymphocytes Indicate an Enhanced Sensitivity to Apoptosis in Sporadic Alzheimer’s Disease , 2001, Dementia and Geriatric Cognitive Disorders.

[17]  Gabriele Siciliano,et al.  Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer’s disease , 2002, Neurobiology of Aging.

[18]  C. Culmsee,et al.  Cellular and Molecular Mechanisms Underlying Perturbed Energy Metabolism and Neuronal Degeneration in Alzheimer's and Parkinson's Diseases , 1999, Annals of the New York Academy of Sciences.

[19]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[20]  J. B. Hutchins,et al.  Bcl‐2 Protects Isolated Plasma and Mitochondrial Membranes Against Lipid Peroxidation Induced by Hydrogen Peroxide and Amyloid β‐Peptide , 1998, Journal of neurochemistry.

[21]  M. Beal Mitochondria, free radicals, and neurodegeneration , 1996, Current Opinion in Neurobiology.

[22]  C. Haass,et al.  Neurotoxic Mechanisms Caused by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation , 2003, Journal of Biological Chemistry.

[23]  S. Kish,et al.  Decreased Brain Protein Levels of Cytochrome Oxidase Subunits in Alzheimer's Disease and in Hereditary Spinocerebella Ataxia Disorders , 1999, Journal of neurochemistry.

[24]  Robert B. Petersen,et al.  Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.

[25]  P. Mecocci,et al.  Oxidative damage to DNA in lymphocytes from AD patients , 1998, Neurology.

[26]  D. Wallace Mitochondrial diseases in man and mouse. , 1999, Science.

[27]  M. Mattson,et al.  Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders , 2002, NeuroMolecular Medicine.

[28]  M. Smith,et al.  Oxidative stress in Alzheimer's disease. , 2000, Biochimica et biophysica acta.

[29]  P Riederer,et al.  Advanced glycation end products in neurodegeneration: More than early markers of oxidative stress? , 1998, Annals of neurology.

[30]  C. Bieberich,et al.  The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice , 1995, Nature Genetics.

[31]  D. Selkoe Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[32]  L. Greene,et al.  β‐Amyloid‐induced neuronal apoptosis requires c‐Jun N‐terminal kinase activation , 2001, Journal of neurochemistry.

[33]  T. Hartmann,et al.  Intracellular biology of Alzheimer’s disease amyloid beta peptide , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[34]  M. Mattson,et al.  β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s Disease , 1994 .

[35]  Miles W. Miller,et al.  Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice , 1999, Nature Medicine.

[36]  Jason P. Sheehan,et al.  Calcium Homeostasis and Reactive Oxygen Species Production in Cells Transformed by Mitochondria from Individuals with Sporadic Alzheimer’s Disease , 1997, The Journal of Neuroscience.

[37]  C. Luckhaus,et al.  Alzheimer's Disease-like Alterations in Peripheral Cells from Presenilin-1 Transgenic Mice , 2001, Neurobiology of Disease.

[38]  M. Mattson,et al.  Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. , 2008, Journal of neurochemistry.

[39]  J. Martinou,et al.  Mitochondria as the central control point of apoptosis. , 2000, Trends in cell biology.

[40]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[41]  J. Land,et al.  β‐Amyloid inhibits integrated mitochondrial respiration 
and key enzyme activities , 2001, Journal of neurochemistry.

[42]  D. Vaux,et al.  A Cinderella Caspase Takes Center Stage , 2002, Science.

[43]  Y. Christen,et al.  Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.

[44]  W. Müller,et al.  β-amyloid peptide decreases membrane fluidity , 1995, Brain Research.

[45]  G. Gibson Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer's disease. , 2002, Free radical biology & medicine.

[46]  J. Parks,et al.  Neurotoxic Aβ peptides increase oxidative stress in vivo through NMDA‐receptor and nitric‐oxide‐synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro , 2001, Journal of neurochemistry.

[47]  Guy C. Brown NO Says Yes to Mitochondria , 2003, Science.

[48]  G. Kroemer,et al.  The mitochondrial death/life regulator in apoptosis and necrosis. , 1998, Annual review of physiology.

[49]  J. Blass,et al.  The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. , 1991, Revue neurologique.

[50]  K. Abe,et al.  Both oxidative stress-dependent and independent effects of amyloid β protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay , 1999, Brain Research.

[51]  J. Thome,et al.  Advanced glycation endproducts in ageing and Alzheimer's disease , 1997, Brain Research Reviews.

[52]  M. Mattson,et al.  Amyloid β-peptide induces apoptosis-related events in synapses and dendrites , 1998, Brain Research.

[53]  D. Harman Free radical theory of aging. , 1992, Triangle; the Sandoz journal of medical science.

[54]  George Perry,et al.  Role of mitochondrial dysfunction in Alzheimer's disease , 2002, Journal of neuroscience research.

[55]  J. Lee,et al.  Amyloid-β Induces Smac Release via AP-1/Bim Activation in Cerebral Endothelial Cells , 2002, The Journal of Neuroscience.

[56]  M. Beal,et al.  High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. , 2002, Human molecular genetics.

[57]  C. Masters,et al.  Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer's disease , 1999, Annals of neurology.

[58]  N. Cairns,et al.  An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease , 1997, Journal of neurochemistry.

[59]  C. Haass,et al.  Elevated vulnerability to oxidative stress‐induced cell death and activation of caspase‐3 by the Swedish amyloid precursor protein mutation , 2001, Journal of neuroscience research.

[60]  N Howell,et al.  Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[61]  T. Arendt,et al.  Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer’s disease , 2001, Brain Research.

[62]  W. Tatton,et al.  Mitochondrial Membrane Potential and Nuclear Changes in Apoptosis Caused by Serum and Nerve Growth Factor Withdrawal: Time Course and Modification by (؊)-deprenyl , 2022 .

[63]  P. Riederer,et al.  Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia. , 2001, Archives of gerontology and geriatrics.

[64]  H. Möller,et al.  A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients , 2000, Neurobiology of Aging.

[65]  John Calvin Reed,et al.  Bcl-2 family proteins and mitochondria. , 1998, Biochimica et biophysica acta.

[66]  M. Schapiro,et al.  Fluorescent light-induced chromatid breaks distinguish Alzheimer disease cells from normal cells in tissue culture. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[67]  G. Sobue,et al.  Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease , 2002, Acta Neuropathologica.

[68]  B. Hyman,et al.  Functional Alterations in Alzheimer's Disease: Selective Loss of Mitochondrial-encoded Cytochrome Oxidase mRNA in the Hippocampal Formation , 1994, Journal of neuropathology and experimental neurology.

[69]  C. Czech,et al.  Presenilins and Alzheimer’s disease: biological functions and pathogenic mechanisms , 2000, Progress in Neurobiology.

[70]  J. Blass,et al.  The α-ketoglutarate dehydrogenase complex in neurodegeneration , 2000, Neurochemistry International.

[71]  H. Wiśniewski,et al.  Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. , 1992, Biochemical and biophysical research communications.

[72]  G. Gibson,et al.  Differential alterations in antioxidant capacity in cells from Alzheimer patients. , 2000, Biochimica et biophysica acta.

[73]  S. Budd,et al.  Mitochondria and neuronal survival. , 2000, Physiological reviews.

[74]  C. Cotman,et al.  Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. , 1991, European journal of pharmacology.

[75]  M. Mattson,et al.  Presenilin mutations and calcium signaling defects in the nervous and immune systems. , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[76]  Hsueh‐Meei Huang,et al.  Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation. , 2003, Biochimica et biophysica acta.

[77]  C. Cotman,et al.  Up‐regulation of Bcl‐2 is associated with neuronal DNA damage in Alzheimer's disease , 1996, NeuroReport.

[78]  C. Cotman,et al.  Caspase-9 Activation and Caspase Cleavage of tau in the Alzheimer's Disease Brain , 2002, Neurobiology of Disease.

[79]  H. Chung,et al.  The frequency of point mutations in mitochondrial DNA is elevated in the Alzheimer's brain. , 2000, Biochemical and biophysical research communications.

[80]  F. Sanger,et al.  Sequence and organization of the human mitochondrial genome , 1981, Nature.

[81]  D. Selkoe Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[82]  Y. Ihara,et al.  Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. , 2000, Biochemistry.

[83]  C. Cotman,et al.  Enhanced vulnerability to apoptotic cell death in sporadic Alzheimer's disease , 1998, Neuroreport.

[84]  J C Reed,et al.  Mechanisms of apoptosis. , 2000, The American journal of pathology.

[85]  William H. Nesse,et al.  Activation of Caspase-8 in the Alzheimer's Disease Brain , 2001, Neurobiology of Disease.

[86]  G. Cortopassi,et al.  A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.